Matribhumi Samachar English
Clearwater, Florida–(Newsfile Corp. – June 15, 2026) – TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) (“TelyRx” or the “Company“), a vertically integrated, technology-enabled healthcare and pharmacy services company, announced today that each of the following nominees proposed to be elected at the Annual Meeting of Shareholders held on Monday, June 15, 2026 (the “Meeting“), has been elected. In addition, the other resolution put to vote at the Meeting was passed.
The detailed results of the vote for the election of directors at the Meeting are set out below.
| Nominee | Votes For (1) | |
| No. | % | |
| Michael Handler | 8,788,172 | 69.42% |
| Vanessa Slowey | 9,188,172 | 72.58% |
| Robert Sean Foley | 9,188,172 | 72.58% |
| Kenneth Bernard | 9,188,172 | 72.58% |
| Ransom Langford | 9,188,172 | 72.58% |
| Andrew Brandt | 12,659,534 | 100.00% |
(1) Withheld votes represent the balance of votes cast in respect of each nominee.
About TelyRx Holdings Inc.
TelyRx is a technology-enabled healthcare and pharmacy services company operating a digital pharmacy platform connecting patients with independent, state-licensed providers to access over 450 everyday medications across 48 U.S. states and territories. The company fulfills prescriptions through its licensed retail pharmacies and offers fast, convenient delivery of medications directly to patients’ doors.
For additional information, visit www.telyrx.com or contact:
Neil Weber
Investor Relations
(647) 222-0574
[email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/301644
